Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H30N2O3.C6H3N3O7 |
| Molecular Weight | 575.5677 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(C=C(C=C1[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O.CCOC(=O)C2(CCN(CCN3CCOCC3)CC2)C4=CC=CC=C4
InChI
InChIKey=OZHVGZNLOCQPAW-UHFFFAOYSA-N
InChI=1S/C20H30N2O3.C6H3N3O7/c1-2-25-19(23)20(18-6-4-3-5-7-18)8-10-21(11-9-20)12-13-22-14-16-24-17-15-22;10-6-4(8(13)14)1-3(7(11)12)2-5(6)9(15)16/h3-7H,2,8-17H2,1H3;1-2,10H
Morpheridine is a pethidine analog with strong analgesic activity. Morpheridine does not cause convulsions, although it produces the standard opioid side effects such as sedation and respiratory depression. Morpheridine is not currently used in medicine and is a Schedule I drug which is controlled under United Nations drug conventions.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2172890-07-0
Created by
admin on Mon Mar 31 23:43:37 GMT 2025 , Edited by admin on Mon Mar 31 23:43:37 GMT 2025
|
PRIMARY | |||
|
Q6A88NLQ9T
Created by
admin on Mon Mar 31 23:43:37 GMT 2025 , Edited by admin on Mon Mar 31 23:43:37 GMT 2025
|
PRIMARY | |||
|
155804798
Created by
admin on Mon Mar 31 23:43:37 GMT 2025 , Edited by admin on Mon Mar 31 23:43:37 GMT 2025
|
PRIMARY | PUBCHEM |
PARENT (SALT/SOLVATE)
SALT/SOLVATE (SALT/SOLVATE)
SUBSTANCE RECORD
